Question 1

What is PEGVISOMANT used for?

Accepted Answer

PEGVISOMANT (brand name SOMAVERT) is a Other indicated for 1 INDICATIONS AND USAGE SOMAVERT is indicated for the treatment of acromegaly in patients who have had an inadequate response to surgery or radiation therapy, or for whom these therapies are not appropriate. The goal of treatment is to normalize serum insulin-like growth factor-1 (IGF-1) levels. ( 1 ).

Question 2

How does PEGVISOMANT work?

Accepted Answer

PEGVISOMANT works through the following mechanism: 12.1 Mechanism of Action Pegvisomant selectively binds to growth hormone (GH) receptors on cell surfaces, where it blocks the binding of endogenous GH, and thus interferes with GH signal transduction. Inhibition of GH action results in decreased serum concentrations of IGF-1, as well as other GH-responsive serum proteins such as free IGF-1, the acid-labile subunit of IGF-1 (ALS), and insulin-like growth factor binding protein-3 (IGFBP-3)..

Question 3

What are the most common side effects of PEGVISOMANT?

Accepted Answer

Reported side effects vary by individual. The side-effects section on this page lists the events most frequently reported to FDA FAERS for PEGVISOMANT. FAERS is voluntary reporting, so it reflects what was reported, not absolute incidence.

Question 4

Is PEGVISOMANT the same as SOMAVERT?

Accepted Answer

SOMAVERT is a brand name for PEGVISOMANT. They share the same active ingredient and FDA-approved indications. Biosimilars and authorised generics may differ in inactive ingredients such as buffers or preservatives.

PEGVISOMANT

Mechanism of Action

Indications

FDA Warnings

Known Side Effects

Community Discussions

Primary sources

Compare With

Formulations